Ibuprofen for COVID-19 symptoms?

Prof Parastou Donyai

writer

Prof Parastou Donyai

Professor and Director of Pharmacy Practice, University of Reading

Prof Parastou Donyai

There’s been some confusion recently on whether we should or shouldn’t take ibuprofen to treat symptoms of COVID-19 – especially after the World Health Organization (WHO) changed its stance. After initially recommending people avoid taking ibuprofen to treat symptoms of the new coronavirus disease, as of March 19 the WHO now does not recommend avoiding ibuprofen to treat COVID-19 symptoms.

The confusion began after France’s Minister of Solidarity and Health Oliver Véran announced on Twitter that taking anti-inflammatory drugs (such as ibuprofen or cortisone) could be a factor in worsening a COVID-19 infection. He recommended that paracetamol should be taken instead to treat the associated fever.

At the moment, the NHS only recommends taking paracetamol for COVID-19 symptoms, even though it admits there is no strong evidence showing ibuprofen worsens symptoms. The BMJ also states that ibuprofen should be avoided when managing COVID-19 symptoms.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Jacob George

Prof Jacob George

Fatty Liver, CV Risk, and Post-Menopause

Prof Sebastian King

Prof Sebastian King

Paediatric Constipation & Related Issues

Hayley Ryan

Hayley Ryan

Management of Skin Tear in General Practice

Dr Katherine Spira

Dr Katherine Spira

Migraine vs Chronic Daily Headache

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.